Synthesis, Characterization, Anticancer, Pharmacokinetic, and Docking Studies of Vanillin-Benzimidazole Derivatives as Aromatase Inhibitors-Reference-Cited by-同舟云学术

Synthesis, Characterization, Anticancer, Pharmacokinetic, and Docking Studies of Vanillin-Benzimidazole Derivatives as Aromatase Inhibitors

Published:2023-12-11 Issue: Volume: Page:1-17
ISSN:1040-6638
Container-title:Polycyclic Aromatic Compounds
language:en
Short-container-title:Polycyclic Aromatic Compounds

Author:

Malebari Azizah M.¹,Nazreen Syed²,Elbehairi Serag Eldin I.³⁴,Elhenawy Ahmed A.²⁵,Abdelhamid Antar A.²⁶,Alfarsi Anas²,Shati Ali A.³,Alqurashi Esam A.²,Alfaifi Mohammad Y.³,Akhtar Mohammad Salman⁷,Alam Mohammad Mahboob²^ORCID

Affiliation:

1. Department of Pharmaceutical Chemistry, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia

2. Department of Chemistry, Faculty of Science, Al-Baha University, Al-Baha, Kingdom of Saudi Arabia

3. Department of Biology, Faculty of Science, King Khalid University, Abha, Saudi Arabia

4. Cell Culture Laboratory, Egyptian Organization for Biological Products and Vaccines, VACSERA Holding Company, Giza, Egypt

5. Chemistry Department, Faculty of Science, Al-Azhar Unuversity, Nasr City, Cairo, Egypt

6. Department of Chemistry, Faculty of Science, Sohag University, Sohag, Egypt

7. Department of Basic Medical Sciences, Faculty of Applied Medical Sciences, Al-Baha University, Al-Baha, Kingdom of Saudi Arabia

Publisher

Informa UK Limited

Subject

Materials Chemistry,Organic Chemistry,Polymers and Plastics

Link

https://www.tandfonline.com/doi/pdf/10.1080/10406638.2023.2289486

Reference54 articles.

1. Discovery of novel indene-based hybrids as breast cancer inhibitors targeting Hsp90: Synthesis, bio-evaluation and molecular docking study

2. Breast Cancer Treatment

3. Aromatase inhibitors: mechanism of action and role in the treatment of breast cancer

4. Novel triazole-tetrahydroisoquinoline hybrids as human aromatase inhibitors

5. The Natural History of Hormone Receptor-Positive Breast Cancer;Lim E.;Oncology,2012